Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Scientific, Inc.

13.27
-0.0800-0.60%
Post-market: 13.300.0300+0.23%17:54 EDT
Volume:10.63M
Turnover:143.71M
Market Cap:3.95B
PE:-4.14
High:13.82
Open:13.37
Low:13.26
Close:13.35
Loading ...
Jun 14, 2024

Proposed Sale Of Securities

Form144|Core Scientific's Officer Todd M.Duchene proposes to sell 26230 Shares, with a total value of approximately $259,562.92.
Jun 14, 2024

Proposed Sale Of Securities

Form144|Core Scientific's Officer Todd M.Duchene proposes to sell 3770 Shares, with a total value of approximately $37,670.97.
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 21, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 29, 2024

Correspondence

Form CORRESP - Correspondence
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 15, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2024

Major Issues Report

Form 8-K - Current report